Intercure
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with… Read more
Intercure (INCR) - Total Assets
Latest total assets as of June 2025: ILA751.76 Million ILA
Based on the latest financial reports, Intercure (INCR) holds total assets worth ILA751.76 Million ILA as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Intercure - Total Assets Trend (2008–2024)
This chart illustrates how Intercure’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Intercure - Asset Composition Analysis
Current Asset Composition (December 2024)
Intercure's total assets of ILA751.76 Million consist of 51.4% current assets and 48.6% non-current assets.
| Asset Category | Amount (ILA) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ILA0.00 | 10.3% |
| Accounts Receivable | ILA180.50 Million | 23.7% |
| Inventory | ILA125.33 Million | 16.4% |
| Property, Plant & Equipment | ILA0.00 | 0.0% |
| Intangible Assets | ILA0.00 | 0.0% |
| Goodwill | ILA224.59 Million | 29.5% |
Asset Composition Trend (2008–2024)
This chart illustrates how Intercure's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Intercure's current assets represent 51.4% of total assets in 2024, an increase from 0.0% in 2008.
- Cash Position: Cash and equivalents constituted 10.3% of total assets in 2024, up from 0.0% in 2008.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 29.0% of total assets, an increase from 0.0% in 2008.
- Asset Diversification: The largest asset category is goodwill at 29.5% of total assets.
Intercure Competitors by Total Assets
Key competitors of Intercure based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Intercure - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Intercure generates 0.31x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Intercure is currently not profitable relative to its asset base.
Intercure - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.85 | 1.78 | 2.28 |
| Quick Ratio | 1.12 | 1.15 | 1.83 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ILA172.03 Million | ILA 161.94 Million | ILA 45.14 Million |
Intercure - Advanced Valuation Insights
This section examines the relationship between Intercure's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.33 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -3.1% |
| Total Assets | ILA762.57 Million |
| Market Capitalization | $367.38K USD |
Valuation Analysis
Below Book Valuation: The market values Intercure's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Intercure's assets decreased by 3.1% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Intercure (2008–2024)
The table below shows the annual total assets of Intercure from 2008 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ILA762.57 Million | -3.06% |
| 2023-12-31 | ILA786.61 Million | -17.89% |
| 2022-12-31 | ILA958.01 Million | +39.59% |
| 2021-12-31 | ILA686.32 Million | +110.35% |
| 2020-12-31 | ILA326.27 Million | +15.60% |
| 2019-12-31 | ILA282.23 Million | +685.73% |
| 2018-12-31 | ILA35.92 Million | +50.00% |
| 2017-12-31 | ILA23.95 Million | -13.66% |
| 2016-12-31 | ILA27.73 Million | +119.75% |
| 2015-12-31 | ILA12.62 Million | +378.04% |
| 2014-12-31 | ILA2.64 Million | -57.17% |
| 2013-12-31 | ILA6.16 Million | -57.57% |
| 2012-12-31 | ILA14.53 Million | +397.71% |
| 2011-12-31 | ILA2.92 Million | +121.66% |
| 2010-12-31 | ILA1.32 Million | -40.65% |
| 2009-12-31 | ILA2.22 Million | -87.61% |
| 2008-12-31 | ILA17.91 Million | -- |